QTc Prolongation: Measure, Correct, and Escalate

QTc prolongation needs action when the corrected QT passes 500 ms or rises at least 60 ms from baseline. The formula you pick changes who gets flagged.

Which QT correction formula should I use?

Pick one formula, name it in the chart, and keep it for every serial ECG. Bazett is the usual machine default, but it overcorrects at fast rates and undercorrects at slow ones, and Fridericia tracks rate better.

A 2016 cohort of 6,609 patients found a QTc/RR slope of -0.071 for Bazett and 0.004 for Fridericia. In its haloperidol arm, Bazett flagged 33 of 107 patients (30.8%) and Fridericia 20 (18.7%).

The 2010 AHA/ACCF statement on preventing torsades in hospitals reads QTc as Bazett unless stated and warns that Bazett overreads above 85 beats per minute. It names no required formula and asks each hospital to fix one protocol for equipment, T-wave end method, formula, and lead.

When do I escalate, and what do I do first?

Escalate a QTc above 500 ms or a rise of at least 60 ms over the pre-drug baseline. Give the prescriber the value, rhythm, electrolytes, and drug list.

The 2010 statement calls a QTc above the 99th percentile (470 ms men, 480 ms women) abnormal and above 500 ms highly abnormal. Each 10 ms rise raises torsades risk roughly 5% to 7%, and a QTc above 500 ms carries 2- to 3-fold higher risk. It carves out amiodarone- and verapamil-induced prolongation, and the 2017 AHA/ACC/HRS ventricular arrhythmia guideline footnotes that amiodarone rarely causes torsades.

Then work through these steps:

1. Document the QTc before starting a QT-prolonging drug and at least every 8 to 12 hours afterward, more often once prolongation appears (2010 statement).
2. Withdraw the offending drug when a drug-induced arrhythmia is presumed (2022 ESC guideline).
3. Replete potassium to 4.0 mmol/L or more for torsades linked to acquired QT prolongation (Class I, C-LD), and IV magnesium sulfate for recurrent torsades (Class I, C-LD) (2017 guideline).
4. For recurrent torsades with bradycardia that magnesium does not suppress, pace or give isoproterenol to raise the rate (Class I, B-NR, 2017 guideline).

The 2010 statement offers 2 g IV magnesium first line regardless of serum level (Class IIa, B). It lists potassium 4.5 to 5 mmol/L as an option on little evidence (Class IIb, C).

How do I adjust the QT with a wide QRS?

Subtract the QRS widening or measure the JT interval, and apply the same method every time. Bundle branch block and pacing lengthen the QT without necessarily changing repolarization, so the 2010 statement says to avoid reading that increase as acquired long QT.

A 2020 study in 71 patients with pacing-induced bundle branch block found the Bogossian formula plus the Hodges rate formula agreed best with intrinsic QTc. Bazett overestimated QTc by about 15 to 20 ms. Check your ECG software and protocol before trusting an auto-corrected number.

What causes QTc prolongation, and how do I check a drug?

Check electrolytes, heart rate, and the drug list first. Search the CredibleMeds QTdrugs list for any drug you are unsure about.

The 2010 statement names these risk factors:

• Female sex (about 2-fold risk), age over 65, bradycardia, heart failure, myocardial infarction, and diuretics.
• Hypokalemia (well established); hypocalcemia only rarely.
• More than one QT-prolonging drug, which raises risk significantly.

The 2017 guideline's Table 10 lists haloperidol, citalopram, ondansetron, methadone, azithromycin, and fluoroquinolones among culprits. It rates QT-prolonging drugs potentially harmful (Class III: Harm, B-NR) in congenital or acquired long QT syndrome.

CredibleMeds sorts drugs into Known (clearly associated with torsades), Possible (lack torsades evidence at recommended use), and Conditional (torsades only under certain conditions) risk. The list is free after registration and updates about every 60 to 90 days. Run it during medication reconciliation and whenever an order adds a second QT-prolonging drug.

Where does this fall short?

The inpatient thresholds come from a 2010 scientific statement rather than a trial, and its authors write that research has not identified the best QT monitoring method. Cutoffs differ by source: the 2016 cohort used 450 and 470 ms for men and women, and the 2010 statement uses 470 and 480 ms. Wide QRS correction rests on small induced-block data. The 2009 AHA/ACCF/HRS ECG standardization statement could not be opened in full, so none of it is cited here, and a search as of 2026-10-10 found no newer AHA hospital-monitoring statement (the search was not exhaustive).